Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.
J Cardiovasc Pharmacol. 2010 Apr;55(4):408-16. doi: 10.1097/FJC.0b013e3181d4ca66.
Myocyte death occurs by necrosis and caspase-mediated apoptosis in myocardial infarction (MI). In vitro studies suggest caspase activation causes myocardial contractile protein degradation without inducing apoptosis. Thus, caspase activation may evoke left ventricular (LV) remodeling through independent processes post-MI. The effects of caspase activation on LV geometry post-MI remain unclear. This project applied pharmacologic caspase inhibition (CASPI) to a porcine model of MI.
Pigs (34 kg) were instrumented to induce 60 minutes of coronary artery occlusion followed by reperfusion and a 7-day follow-up period. Upon reperfusion, the pigs were randomized to saline (n = 12) or CASPI (n = 10, IDN6734, 6 mg/kg i.v., then 6 mg/kg/h for 24 hours). Plasma troponin-I values were reduced with CASPI compared with saline at 24 hours post-MI (133 +/- 15 vs. 189 +/- 20 ng/mL, respectively, P < 0.05). LV end-diastolic area (echocardiography) and interregional length (sonomicrometry) increased from baseline in both groups but were attenuated with CASPI by 40% and 90%, respectively (P < 0.05). Myocyte length was reduced with CASPI compared with saline (128 +/- 3 vs. 141 +/- 4 microm, respectively, P < 0.05). Plasma-free pro-matrix metalloproteinase-2 values increased from baseline with CASPI (27% +/- 6%, P < 0.05) indicative of reduced conversion to active MMP-2. Separate in vitro studies demonstrated that activated caspase species cleaved pro-MMP-2 yielding active MMP-2 forms and that MMP activity was increased in the presence of activated caspase-3.
CASPI attenuated regional and global LV remodeling post-MI and altered viable myocyte geometry. Caspases increased MMP activity in vitro, whereas CASPI modified conversion of MMP-2 to the active form in vivo. Taken together, the results of the present study suggest that the elaboration of caspases post-MI likely contribute to LV remodeling through both cellular and extracellular mechanisms.
心肌梗死(MI)中的肌细胞死亡通过坏死和半胱天冬酶介导的凋亡发生。体外研究表明,半胱天冬酶激活导致心肌收缩蛋白降解而不诱导凋亡。因此,半胱天冬酶激活可能通过 MI 后独立的过程引发左心室(LV)重构。半胱天冬酶激活对 MI 后 LV 几何形状的影响尚不清楚。本项目在 MI 的猪模型中应用了药理学半胱天冬酶抑制(CASPI)。
猪(34 公斤)被仪器化以诱导 60 分钟的冠状动脉闭塞,随后再灌注和 7 天的随访期。再灌注时,猪被随机分为盐水(n = 12)或 CASPI(n = 10,IDN6734,6mg/kg iv,然后 24 小时内 6mg/kg/h)。与盐水相比,CASPI 可降低 MI 后 24 小时的血浆肌钙蛋白 I 值(分别为 133 +/- 15 与 189 +/- 20 ng/mL,P < 0.05)。LV 舒张末期面积(超声心动图)和区域性长度(超声心动图)在两组中均从基线增加,但 CASPI 分别减轻了 40%和 90%(P < 0.05)。与盐水相比,CASPI 使肌细胞长度减少(分别为 128 +/- 3 与 141 +/- 4 μm,P < 0.05)。与基线相比,CASPI 使血浆游离基质金属蛋白酶-2 值增加(27% +/- 6%,P < 0.05),表明 MMP-2 向活性 MMP-2 的转化减少。单独的体外研究表明,激活的半胱天冬酶切割 pro-MMP-2 产生活性 MMP-2 形式,并且在存在激活的 caspase-3 的情况下 MMP 活性增加。
CASPI 减轻了 MI 后区域性和全球性 LV 重构,并改变了存活的肌细胞几何形状。半胱天冬酶在体外增加了 MMP 活性,而 CASPI 在体内改变了 MMP-2 向活性形式的转化。综上所述,本研究的结果表明,MI 后半胱天冬酶的表达可能通过细胞内和细胞外机制共同导致 LV 重构。